Search Results - "Nareyko, Maria"

Recovery of Donor Hematopoiesis after Graft Failure and Second Hematopoietic Stem Cell Transplantation with Intraosseous Administration of Mesenchymal Stromal Cells by Nareyko, Maria, Firsova, Maya, Kuzmina, Larisa A., Parovichnikova, Elena N., Savchenko, Valery G., Kraizman, Alina, Dubniak, Daria, Drokov, Michail, Sudarikov, Andrey, Risinskaya, Natalya, Sats, Natalia, Drize, Nina J., Petinati, Natalia A., Popova, Natalia

“…Multipotent mesenchymal stromal cells (MSCs) participate in the formation of bone marrow niches for hematopoietic stem cells. Donor MSCs can serve as a source…”
Get full text

High expression of granzyme B in conventional CD4+ T cells is associated with increased relapses after allogeneic stem cells transplantation in patients with hematological malignancies by Drokov, Mikhail, Davydova, Yulia, Popova, Natalia, Kapranov, Nikolay, Starikova, Olga, Mikhaltsova, Ekaterina, Nareyko, Maria, Dmitrova, Anna, Konova, Zoya, Galtseva, Irina, Kuzmina, Larisa, Parovichnikova, Elena, Savchenko, Valery

“…Granzyme B is known to be a serine protease contained in granules of cytotoxic T cells. We have previously reported an influence of granzyme B expression in T…”
Get full text

Impact of Minimal Residual Disease Detected By Multiparameter Flow Cytometry on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Patients in First Complete Remission by Konova, Zoya V., Parovichnikova, Elena N., Galtseva, Irina V., Kapranov, Nikolay M., Davydova, Julia O., Drokov, Mikhail Yu, Nareyko, Maria V., Popova, Natalia N., Dmitrova, Anna A., Maslikova, Ulyana V., Starikova, Olga S., Usikova, Ekaterina I., Mikhaltsova, Ekaterina D., Koroleva, Olga M., Vasilyeva, Vera A., Lobanova, Tatiana I., Kuzmina, Larisa A., Savchenko, Valeriy G.

“…Introduction. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) could be curative for acute myeloid leukemia (AML) patients. However, the disease…”
Get full text

Molecular and Biological Characteristics of Tumour Substrate in Patients with Extramedullary Multiple Myeloma by Firsova, Maya V., Mendeleeva, Larisa P., Kovrigina, Alla M., Deineko, Natalia L., Solovev, Maxim V., Nareyko, Maria V., Kuzmina, Larisa A., Savchenko, Valery G.

“…Introduction. At the time of the diagnosis of MM the incidence of extramedullary disease (EMD) varies from 7 to 18%, and in case of à relapse, it is observed…”
Get full text

Histopathological Features of Bone Marrow and Extramedullary Sites in Patients with Multiple Myeloma by Firsova, Maiia V., Mendeleeva, Larisa P., Kovrigina, Alla M., Pokrovskaya, Olga S., Deineko, Natalia L., Solovev, Maxim V., Nareyko, Maria V., Kuzmina, Larisa A., Gemdzhian, Eduard G., Savchenko, Valeriy G.

“…Background: Due to new imaging modalities such as low-dose whole body CT, MRI, and PET-CT which are characterized with high sensitivity and specificity…”
Get full text

The Duration of MRD-Negative Status in Multiple Myeloma (MM) Patients after Auto-HSCT Is a Criterion for Prolonged Remission without Maintenance Therapy by Solovev, Maxim V., Mendeleeva, Larisa P., Pokrovskaya, Olga S., Gemdzhian, Eduard G., Kuzmina, Larisa A., Firsova, Maiia V., Nareyko, Maria V., Galtseva, Irina V., Davydova, Julia O., Savchenko, Valeriy G.

“…Background:Achievement of MRD-negative status in MM patients following auto-HSCT is a prognostic factor that has a positive effect on relapse-free survival…”
Get full text

Correlation Between c-MYC Gene Expression and Response after Induction Therapy Among Patients with Newly Diagnosed Multiple Myeloma and Monoclonal Gammopathy Undetermined Significance by Nareyko, Maria, Mendeleeva, Larisa P., Surin, Vadim, Demidova, Ekaterina, Pokrovskaya, Olga S., Kuzmina, Larisa A., Gribanova, Elena, Rizhko, Vyacheslav, Galtseva, Irina, Urnova, Evdokia S., Drokov, Mihail, Firsova, Maia, Solovev, Maksim, Boeva, Eleonora, Koroleva, Olga, Nakastoev, Islam, Grachev, Aleksander, Kanaeva, Madina, Danilina, Anjelika, Parovichnikova, Elena N., Savchenko, Valeri G.

“…Introduction. Patients (pts) with oncopathology who have hyperexpression of c-MYC demonstrate low response to chemotherapy and poor prognosis. In our study we…”
Get full text